US 7,611,713 B2Granted

Inducing cellular immune responses to hepatitis B virus using peptide compositions

AssigneePharmexa Inc.

InventorsAlessandro Sette, John Sidney, Scott Southwood, Maria Vitiello, Brian Livingston, Esteban Celis, Ralph Kubo, Howard Grey, Robert Chesnut

Life of this patent

Estimating the term…

Abstract

This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to develop epitope-based vaccines directed towards HBV. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of HBV infection.

Claims5

Dependent claims

An isolated peptide consisting of the oligopeptide LWFHISCLTF (SEQ ID NO:879).

Dependencies are inferred from the claim text.

Facts

Application: 10/654,601Filed 4 Sep 2003 · division
Priority: 27 Jan 1999
Published: US 2005/0063983 A124 Mar 2005
Granted: 3 Nov 2009
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses
A61P 31/12
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antivirals
C07K 14/70539
Immunoglobulin superfamily: mHC-molecules, e.g. HLA-molecules
A61K 38/00
Medicinal preparations containing peptides

Family

Application09/239,043Parent of this division · filed 27 Jan 1999
US 2005/0063983 A1Pre-grant publication · published 24 Mar 2005
US 6,689,363 B1Parent of this division
US 7,611,713 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results